DOUBLE JEOPARDY: HIGH ANEMIA PREVALENCE IN UNDERWEIGHT AND OBESE YOUNG MEN: A PAKISTANI PERSPECTIVE ON ANDROLOGICAL HEALTH

Main Article Content

Noman Sadiq
Jamshed Warsi
Mukhtiar Ahmed
Abdul Samad
Muhammad Tahir
Somia Iqbal

Keywords

Anemia, Body mass index, Hemoglobin, Male hypogonadism, Testosterone, Obesity

Abstract

Objective: To determine the association between body mass index (BMI) categories and anemia prevalence in young adult males and its potential impact on andrological well-being.


Methodology: This Cross-sectional study was conducted at Teaching Hospital Turbat, from February 2024 to August 2024. One hundred and eighty-six young males aged 18-40 years were recruited using convenient purposive sampling. Anemia was defined as hemoglobin <13 g/dL. BMI was categorized as underweight (<18.5 kg/m²), normal (18.5-24.9 kg/m²), overweight (25-29.9 kg/m²), and obese (≥30 kg/m²). Complete blood count was performed using automated hematology analyzer. Data was analyzed using SPSS version 25.0.


Results: Mean age was 30.45±5.82 years. Overall anemia prevalence was 30.1% (56/186). A U-shaped relationship was observed: underweight 72.7% (8/11), normal weight 30.0% (30/100), overweight 16.7% (9/54), and obese 42.9% (9/21). Significant negative correlation (r=-0.287, p<0.001) was found between BMI and hemoglobin. Mean hemoglobin was lowest in underweight (11.82±1.45 g/dL) and obese (12.23±1.78 g/dL) groups.


Conclusion: Both extremes of BMI showed remarkably high anemia prevalence. Given the established link between anemia and testosterone deficiency, these findings have important implications for male reproductive health and andrological well-being.

Abstract 107 | Pdf Downloads 29

References

1. WHO. Anaemia in women and children. Geneva: World Health Organization; 2021. Available from: https://www.who.int/data/gho/data/themes/topics/anaemia_in_women_and_children
2. Ali K, Talati J, Mikulas C, Quan A, Reddy P. Testosterone Therapy for the Treatment of Unexplained Anemia in Men With Hypogonadism. Cureus. 2024;16(8):e66887.
3. Pencina KM, Travison TG, Artz AS, Lincoff AM, Nissen SE, Flevaris P, et al. Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(10):e2340030.
4. National SAMSA. Obesity in Pakistan: A Silent Epidemic. 2023. Available from: https://nationalsamsa.org/2023/02/22/obesity-in-pakistan-a-silent-epidemic-2/
5. Jafar TH, Haaland BA, Rahman A, Razzak JA, Bilger M, Naghavi M, et al. Non-communicable diseases and injuries in Pakistan: strategic priorities. Lancet. 2020;395(10241):2072-83.
6. Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-44.
7. Wang J, Chen X, Zhang L, Li Y, Liu H. Anemia and testosterone deficiency risk: insights from NHANES data analysis and a Mendelian randomization analysis. Aging Male. 2024;27(1):2346312.
8. Ahmed J, Laghari A, Naseer M, Mehraj V. Prevalence of and factors associated with obesity among Pakistani schoolchildren: a school-based, cross-sectional study. East Mediterr Health J. 2013;19(3):242-7.
9. Ahmad MS, Asif M, Aslam M, Ali M. Body mass index and anemia among adult men and women in Pakistan: Analysis of demographic and health survey data. Pak J Med Sci. 2023;39(4):1089-94.
10. Khan MS, Zahid S, Ishaq M. Prevalence and predictors of anemia among adults in Pakistan: Findings from a national survey. BMC Public Health. 2023;23(1):1624.
11. Alibhai SMH. Testosterone Replacement in Men With Hypogonadism and Effects on Anemia-Blood, Sex, and Aging. JAMA Netw Open. 2023;6(10):e2339969.
12. Bhasin S, Lincoff AM, Basaria S, Bauer DC, Boden WE, Cunningham GR, et al. Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: rationale and design of the TRAVERSE study. Am Heart J. 2022;245:41-50.
13. Low Testosterone (Male Hypogonadism). Cleveland Clinic. 2023. Available from: https://my.clevelandclinic.org/health/diseases/15603-low-testosterone-male-hypogonadism
14. Zhang H, Liu Y, Wang L, Li M, Chen J. Association between anemia and testosterone deficiency in men: evidence from NHANES and Mendelian randomization. Front Endocrinol. 2024;15:1389453.
15. Wikipedia. Obesity in Pakistan. 2024. Available from: https://en.wikipedia.org/wiki/Obesity_in_Pakistan
16. McClung JP, Karl JP. Iron deficiency and obesity: the contribution of inflammation and diminished iron absorption. Nutr Rev. 2009;67(2):100-4.
17. Bachman E, Travison TG, Basaria S, Davda MN, Guo W, Li M, et al. Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci. 2014;69(6):725-35.
18. Ahmed S, Khan A, Ali N, Rauf A. Understanding childhood obesity in Pakistan: exploring the knowledge, attitudes, practices of mothers, and influential factors. A cross-sectional study. Front Public Health. 2024;12:1475455.
19. Tariq S, Jamali AA, Mukhtar S, Sultana M, Azhar S. Metabolic syndrome and obesity among marginalised school-going adolescents in Karachi, Pakistan: a cross-sectional study. Lancet Reg Health Southeast Asia. 2024;27:100400.
20. Ferrucci L, Maggio M, Bandinelli S, Basaria S, Lauretani F, Ble A, et al. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med. 2006;166(13):1380-8.

Most read articles by the same author(s)

1 2 > >>